US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

771.39

-3.9864-0.51%

Number of Gainers:1

Number of Losers:3

Number of Flat:- -

PE:- -

High:794.43

Open:776.48

Low:770.13

Close:775.38

Volume:40.09M

Turnover:622.91M

Market Cap:24.95B

Float Cap:18.97B

Loading ...

Tempus AI Diagnostics CEO Thomas Edward Schoenherr Disposes of $873,885 in Common Shares

Tempus AI Wins FDA Clearance for ECG-MR Tool to Flag Undiagnosed Mitral Regurgitation

Tempus Receives FDA Clearance for Its Ecg-Mr AI Product Designed to Identify Undiagnosed Mitral Regurgitation

THOMSON REUTERS

ToolGen Raises KRW 19.5 Billion to Fund CRISPR Patent Battles and R&D

Snowflake, Palo Alto, Dell, GameStop, Crispr Insider Shock

Crispr Therapeutics General Counsel James R. Kasinger Disposes of Common Shares Worth $626,459.6

Tempus AI CEO and Chairman Eric P. Lefkofsky Disposes of $17,868,777.62 in Class a Shares

Tempus AI Inc Stock (TEM) Closed Up by 7.38% on Sep 24: What Investors Need To Know

tempus AI Inc Class A call volume above normal and directionally bullish

Editas slips amid pressure on gene-editing sector after Anthropic update

Claude discovers novel enzyme system with CRISPR-like repeats

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Avantor (AVTR)

Cathie Wood’s ARK Investment buys 103K shares of Beam Therapeutics today

Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24

Recursion Licenses TxFM RNA Foundation Model to Tempus AI for Oncology Use in USD 12 Million Deal

Tempus Extends Data Licensing Partnership with Recursion Through November 2029

Tempus AI, Recursion Extend Data License, Amend Fee Structure

MT Newswires Live

Recursion, Tempus Expand AI and RNA Collaboration Agreements

Tempus AI, Recursion extend data license agreement, enter new license agreement

Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BK4611/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":771.38983,"timestamp":1790798399999,"preClose":775.3762,"halted":0,"volume":40092796,"delay":0,"changeRate":-0.005141,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-3.986389,"latestTime":"09-30 16:00:00 EDT","open":776.4839,"high":794.4314,"low":770.12744,"amount":622910705.239491,"amplitude":0.031345,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.98642,"peRate":-19.059883,"turnoverRate":0.048769,"increases":1,"decrements":3,"flats":0,"marketCap":24953417728,"floatMarketCap":18969360640},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":794.4314,"amplitude":0.031345,"preClose":775.3762,"low":770.12744,"pbRate":"5.98642","latestPrice":771.38983,"volume":40092796,"delay":0,"open":776.4839,"prevYearClose":658.3995,"prevWeekClose":773.7466,"prevMonthClose":691.9381,"prevQuarterClose":681.0329,"fiveDayClose":738.6179,"twentyDayClose":684.6236,"sixtyDayClose":732.3159,"secType":"PLATE","market":"US","turnoverRate":0.048769,"peRate":-19.059883,"marketCap":24953417728,"floatMarketCap":18969360640,"timestamp":1790798399999,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":1,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671427342","title":"Tempus AI Diagnostics CEO Thomas Edward Schoenherr Disposes of $873,885 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2671427342","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671427342?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:15","pubTimestamp":1790712957,"startTime":"0","endTime":"0","summary":"Tempus AI Diagnostics CEO Thomas Edward Schoenherr disposes of $873,885 in common sharesTempus AI officer Thomas Edward Schoenherr, CEO of Diagnostics, sold 10,281 Class A common shares on Sept. 25, 2","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL2n4htK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI Diagnostics CEO Thomas Edward Schoenherr Disposes of $873,885 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4611","TEMC","TEMT","ARKG","LU1861559042.SGD","TEM","HEAL","LU1861558580.USD","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670823256","title":"Tempus AI Wins FDA Clearance for ECG-MR Tool to Flag Undiagnosed Mitral Regurgitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2670823256","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670823256?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:03","pubTimestamp":1790597023,"startTime":"0","endTime":"0","summary":"Tempus AI wins FDA clearance for ECG-MR tool to flag undiagnosed mitral regurgitationTempus AI received FDA 510(k) clearance for ECG-MR, an AI tool that flags signs linked to undiagnosed moderate or s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL4wD0vJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4613","LU1861559042.SGD","LU1861558580.USD","TEMC","BK4121","TEMT","TEM","HEAL","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670340602","title":"Tempus Receives FDA Clearance for Its Ecg-Mr AI Product Designed to Identify Undiagnosed Mitral Regurgitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2670340602","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670340602?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:00","pubTimestamp":1790596801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUA4XYFL9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARKG","LU1861559042.SGD","BK4121","TEMT","TEMC","LU1861558580.USD","BK4613","BK4611","TEM","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670484284","title":"ToolGen Raises KRW 19.5 Billion to Fund CRISPR Patent Battles and R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2670484284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670484284?lang=en_us&edition=fundamental","pubTime":"2026-09-28 15:14","pubTimestamp":1790579642,"startTime":"0","endTime":"0","summary":"ToolGen Incorporated ( ($KR:199800) ) has shared an update. ToolGen has completed a KRW 19.46 billion paid-in capital increase via a rights offerin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/toolgen-raises-krw-19-5-billion-to-fund-crispr-patent-battles-and-rd?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/toolgen-raises-krw-19-5-billion-to-fund-crispr-patent-battles-and-rd?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","BK4139","LU1861558580.USD","BK4588","ARKG","BK4585","BK4611","BK4556","SYNB","CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670471230","title":"Snowflake, Palo Alto, Dell, GameStop, Crispr Insider Shock","url":"https://stock-news.laohu8.com/highlight/detail?id=2670471230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670471230?lang=en_us&edition=fundamental","pubTime":"2026-09-26 21:00","pubTimestamp":1790427654,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($SNOW)), (($PANW)), (($DELL)), (($GME)) and (($CRSP)). Here is a breakdown of their recent trades and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/snowflake-palo-alto-dell-gamestop-crispr-insider-shock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/snowflake-palo-alto-dell-gamestop-crispr-insider-shock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BUG","LU2023250504.SGD","PALD","LU2065171402.SGD","LU0345770993.USD","GME","CLOU","LU1267930227.SGD","LU2125909916.SGD","IHAK","LU2322448791.USD","LU2360107168.USD","LU1169589451.USD","LU2023250843.SGD","LU0128525689.USD","LU0823421333.USD","LU2272731865.HKD","LU0082616367.USD","LU0348723411.USD","DAT","WISE","LU1548497426.USD","LU0234570918.USD","LU0097036916.USD","LU2290526834.HKD","LU1951198990.SGD","LU1861559042.SGD","LU0109392836.USD","PALU","LU0719512351.SGD","LU1235294995.USD","BK4551","LU0823434740.USD","BK4556","SNOU","BK4547","BK4577","LU2355687059.USD","LU2357305700.SGD","ARKG","LU1046421795.USD","GMEC","LU1989764664.SGD","LU2322448957.HKD","LU1623119135.USD","LU2272731782.SGD","BK4613","IE00BMPRXN33.USD","FXL","LU0266013472.USD","SNOY","LU1720051108.HKD","LU0823421416.USD","LU2065170008.USD","DELL","LU2065171311.SGD","XDAT","GMEU","IE00BZ1G4Q59.USD","LU0081259029.USD","IE00BKVL7J92.USD","BK4505","BK4585","LU1803068979.SGD","BK4170","WCLD","LU0496365809.HKD","LU1861220033.SGD","SNOW","HAKY","LU0211326839.USD","PANW","LU1951200564.SGD","LU1989764748.USD","BK4548","CLOD","LU1974910355.USD","SPAM","BK4611","LU1917777945.USD","LU2272731600.USD","BK4097","LU0889565833.HKD","LU0267386448.USD","LU1861558580.USD","BK4554","LU2210149790.SGD","BK4560","LU1923623000.USD","BK4116","IGV","LU0345770308.USD","LU2095319765.USD","LU0211326755.USD","BK4607","BK4076","BK4543","IE00B19Z9505.USD","LU1861215975.USD","BK4535","LU1992135472.HKD","BK4503","LU2210150020.SGD","IE00B19Z8X17.USD","LU1823568750.SGD","BK4139","LU2286300806.USD","BK4588","LU1804176565.USD","IGME","BK4598","LU2473716301.USD","LU2265009873.SGD","BK4532","IE00BMPRXR70.SGD","CIBR","PSWD","LU0310800965.SGD","BK4559","LU1923622291.USD","PANG","LU2106854487.HKD","LU1169590202.USD","LU2125909759.SGD","LU2250418816.HKD","SG9999001424.SGD","LU2360106780.USD","LU1720051017.SGD","LU0976567544.SGD","LU2065169927.USD","DLLL","IE00B19Z8W00.USD","GMEY","LU1992135399.USD","LU0056508442.USD","LU0052756011.USD","CRSP","LU1712237335.SGD","WLDR","BK4515","AIFD","BK4550","BK4581","LU1852331112.SGD","WCBR","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670413710","title":"Crispr Therapeutics General Counsel James R. Kasinger Disposes of Common Shares Worth $626,459.6","url":"https://stock-news.laohu8.com/highlight/detail?id=2670413710","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670413710?lang=en_us&edition=fundamental","pubTime":"2026-09-25 05:35","pubTimestamp":1790285746,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics General Counsel James R. Kasinger disposes of common shares worth $626,459.6James R. Kasinger, general counsel and secretary, sold 10,400 common shares on Sept. 22 at USD 60.2365.T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL3lyBzR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Crispr Therapeutics General Counsel James R. Kasinger Disposes of Common Shares Worth $626,459.6","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4588","CRSP","BK4556","LU1861559042.SGD","LU1861558580.USD","ARKG","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670597418","title":"Tempus AI CEO and Chairman Eric P. Lefkofsky Disposes of $17,868,777.62 in Class a Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2670597418","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670597418?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:15","pubTimestamp":1790280957,"startTime":"0","endTime":"0","summary":"Tempus AI CEO and Chairman Eric P. Lefkofsky disposes of $17,868,777.62 in Class A sharesEric P. Lefkofsky, CEO and chairman, disclosed sales of Tempus AI Class A common stock on Sept. 22, 2026.Transa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDLbkPm47:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI CEO and Chairman Eric P. Lefkofsky Disposes of $17,868,777.62 in Class a Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","LU1861559042.SGD","TEM","LU1861558580.USD","HEAL","TEMT","TEMC","BK4613","ARKG","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670418657","title":"Tempus AI Inc Stock (TEM) Closed Up by 7.38% on Sep 24: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2670418657","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670418657?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:15","pubTimestamp":1790280916,"startTime":"0","endTime":"0","summary":"• Tempus AI saw strong buying driven by institutional interest in precision medicine.\n• Wall Street analysts raised forward earnings estimates and revenue growth forecasts.\n• The company reported an annual revenue of $1.27 billion.","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262185696-market-movers-tem-20260924","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM","BK4613","TEMT","BK4611","TEMC","BK4121","HEAL","ARKG","LU1861558580.USD","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670349079","title":"tempus AI Inc Class A call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2670349079","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670349079?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:45","pubTimestamp":1790279111,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in tempus AI (TEM) Inc Class A with 37,025 calls trading, 1.7x expected, and implied vol increasing almost 5 points to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-inc-class-a-call-volume-above-normal-and-directionally-bullish-thefly-news-6?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-inc-class-a-call-volume-above-normal-and-directionally-bullish-thefly-news-6?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4613","BK4121","LU1861558580.USD","TEM","LU1861559042.SGD","HEAL","TEMC","ARKG","TEMT","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669435367","title":"Editas slips amid pressure on gene-editing sector after Anthropic update","url":"https://stock-news.laohu8.com/highlight/detail?id=2669435367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669435367?lang=en_us&edition=fundamental","pubTime":"2026-09-24 02:55","pubTimestamp":1790189712,"startTime":"0","endTime":"0","summary":"Editas Medicine (EDIT) is trading lower alongside other gene editing peers after Anthropic shared early findings on a CRISPR like enzyme system. An...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/editas-slips-amid-pressure-on-gene-editing-sector-after-anthropic-update-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/editas-slips-amid-pressure-on-gene-editing-sector-after-anthropic-update-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4611","BK4588","GNMX","BK4139","CRSP","LU1861558580.USD","IDNA","HELX","SYNB","BK4556","LU1861559042.SGD","ARKG","WDNA","EDIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669433986","title":"Claude discovers novel enzyme system with CRISPR-like repeats","url":"https://stock-news.laohu8.com/highlight/detail?id=2669433986","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669433986?lang=en_us&edition=fundamental","pubTime":"2026-09-24 02:15","pubTimestamp":1790187313,"startTime":"0","endTime":"0","summary":"Anthropic is introducing a new life sciences research group and laboratory, with a focus on fundamental biology research using Claude – exploring d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claude-discovers-novel-enzyme-system-with-crispr-like-repeats-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claude-discovers-novel-enzyme-system-with-crispr-like-repeats-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","BK4588","BK4611","LU1861558580.USD","BK4585","BK4556","LU1861559042.SGD","SYNB","BK4139","CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669110468","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Avantor (AVTR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669110468","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669110468?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:10","pubTimestamp":1790068204,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tempus AI, Inc. Class A (TEM) and Avantor (AVTR). Tempus AI, Inc....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-tempus-ai-inc-class-a-tem-and-avantor-avtr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-tempus-ai-inc-class-a-tem-and-avantor-avtr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","LU0006061336.USD","TEM","TEMC","TEMT","AVTR","BK4121","LU1861558580.USD","LU1861559042.SGD","BK4613","BK4611","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669911491","title":"Cathie Wood’s ARK Investment buys 103K shares of Beam Therapeutics  today","url":"https://stock-news.laohu8.com/highlight/detail?id=2669911491","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669911491?lang=en_us&edition=fundamental","pubTime":"2026-09-22 08:30","pubTimestamp":1790037011,"startTime":"0","endTime":"0","summary":"20:28 EDT Cathie Wood’s ARK Investment buys 103K shares of Beam Therapeutics (BEAM) today Published first on TheFly – the ultimate source for real-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-103k-shares-of-beam-therapeutics-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-103k-shares-of-beam-therapeutics-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKX","BK4588","BK4007","BEAM","ARKG","ARKW","BK4585","BK4505","ARKK","BK4539","BK4611","ARKQ","ARKF","LU1861558580.USD","BK4544","LENZ","SARK","BK4556","BK4139","LU1861559042.SGD","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669843196","title":"Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2669843196","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669843196?lang=en_us&edition=fundamental","pubTime":"2026-09-22 06:41","pubTimestamp":1790030476,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics director Ali Behbahani disposes of common shares worth $780,649.24CRISPR Therapeutics director Ali Behbahani exercised stock options for 30,000 common shares at USD 14 on Sept. 17,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL112S6t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","ARKG","BK4139","BK4611","BK4588","BK4585","BK4556","CRSP","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669162636","title":"Recursion Licenses TxFM RNA Foundation Model to Tempus AI for Oncology Use in USD 12 Million Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669162636","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669162636?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:18","pubTimestamp":1790007493,"startTime":"0","endTime":"0","summary":"Recursion licenses TxFM RNA foundation model to Tempus AI for oncology use in USD 12 million dealRecursion Pharmaceuticals expanded its data partnership with Tempus AI, extending the term to six years","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL7Y7sX8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMT","BK4121","BK4548","BK4139","TEM","BK4539","RXRX","BK4609","LU1861559042.SGD","LU1861558580.USD","TEMC","ARKG","HEAL","BK4613","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669162688","title":"Tempus Extends Data Licensing Partnership with Recursion Through November 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2669162688","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669162688?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:17","pubTimestamp":1790007444,"startTime":"0","endTime":"0","summary":"Tempus extends data licensing partnership with Recursion through November 2029Tempus extended its multi-year data license partnership with Recursion through November 2029.Deal resets original master a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL8vkn23:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","BK4139","BK4611","TEMT","TEM","BK4548","BK4539","LU1861558580.USD","LU1861559042.SGD","BK4613","HEAL","TEMC","BK4121","BK4609","RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669161540","title":"Tempus AI, Recursion Extend Data License, Amend Fee Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669161540","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669161540?lang=en_us&edition=fundamental","pubTime":"2026-09-21 22:36","pubTimestamp":1790001417,"startTime":"0","endTime":"0","summary":"Tempus AI  and Recursion Pharmaceuticals  extended their data license agreement through November 2029 and revised the contract's fee structure.Up to $84 million in discretionary payments over the next two years will be replaced with $42 million in committed payments over three years, Tempus said Monday in a statement.Tempus said it also signed a separate agreement granting the company a nonexclusive, worldwide license to Recursion's proprietary RNA sequencing model.Tempus shares rose 1.8% in Monday trading, and Recursion climbed 2.6%.Price: 79.27, Change: +1.43, Percent Change: +1.83","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RXRX","LU1861559042.SGD","ARKG","BK4613","BK4611","BK4539","BK4548","TEM","LU1861558580.USD","TEMC","HEAL","BK4609","TEMT","BK4121","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169875","title":"Recursion, Tempus Expand AI and RNA Collaboration Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169875","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169875?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:29","pubTimestamp":1789997370,"startTime":"0","endTime":"0","summary":"The latest update is out from Recursion Pharmaceuticals ( ($RXRX) ). On September 15, 2026, Recursion Pharmaceuticals amended its long-term data an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/recursion-tempus-expand-ai-and-rna-collaboration-agreements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/recursion-tempus-expand-ai-and-rna-collaboration-agreements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEMC","BK4611","BK4539","BK4613","TEMT","ARKG","BK4139","HEAL","RXRX","BK4609","LU1861558580.USD","LU1861559042.SGD","BK4121","BK4548","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169889","title":"Tempus AI, Recursion extend data license agreement, enter new license agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169889?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:20","pubTimestamp":1789996814,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced an extension of its data license agreement with Recursion Pharmaceuticals (RXRX). Additionally, the two companies have en...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-recursion-extend-data-license-agreement-enter-new-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-recursion-extend-data-license-agreement-enter-new-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4609","BK4611","RXRX","BK4613","LU1861558580.USD","ARKG","BK4548","TEMT","BK4139","HEAL","TEM","TEMC","BK4121","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669666681","title":"Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm","url":"https://stock-news.laohu8.com/highlight/detail?id=2669666681","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669666681?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RXRX","BK4539","BK4613","LU1861559042.SGD","BK4548","TEM","TEMC","ARKG","BK4121","BK4611","HEAL","BK4139","LU1861558580.USD","BK4609","TEMT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}